| Medtronic plc | $119.2b | $93.43 | +2.5% | 5.2M | |
| Edwards Lifesciences Corp | $52.3b | $85.33 | +1.1% | 1.3M | |
| Alcon Inc. Ordinary Shares | $34.9b | $67.53 | +2.3% | 1.0M | |
| Biogen Inc. Common Stock | $32.9b | $217.92 | +0.2% | 273.1K | |
| Zimmer Biomet Holdings, Inc. | $18.9b | $96.07 | +2.7% | 954.9K | |
| Glaukos Corporation | $10.6b | $169.69 | +1.1% | 249.2K | |
| Bausch + Lomb Corporation | $6.4b | $17.43 | +0.8% | 92.3K | |
| Denali Therapeutics Inc. Common Stock | $3.7b | $21.36 | +1.1% | 493.6K | |
| Bioventus Inc. Class A Common Stock | $1.0b | $13.19 | +1.4% | 142.1K | |
| Anteris Technologies Global Corp. Common Stock | $0.8b | $8.55 | +2.5% | 268.1K | |
| BioAge Labs, Inc. Common Stock | $446.6m | $8.48 | +0.2% | 241.4K | |
| Alector, Inc. Common Stock | $303.7m | $2.17 | +1.4% | 1.8M | |
| AC Immune SA | $282.4m | $2.67 | -2.9% | 76.1K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $224.2m | $2.90 | -0.5% | 278.4K | |
| Alpha Cognition Inc. Common Stock | $202.9m | $8.66 | -2.2% | 74.1K | |
| LENZ Therapeutics, Inc. Common Stock | $182.2m | $4.47 | -0.7% | 432.3K | |
| Outlook Therapeutics, Inc. Common Stock | $157.5m | $0.65 | -0.3% | 1.5M | |
| Cognition Therapeutics, Inc. Common Stock | $99.8m | $1.01 | +3.3% | 166.2K | |
| Telomir Pharmaceuticals, Inc. Common Stock | $79.8m | $1.22 | 0.0% | 26.8K | |
| Annovis Bio, Inc. | $72.4m | $1.14 | +1.8% | 683.1K | |
| Envoy Medical, Inc. Class A Common Stock | $53.3m | $0.74 | 0.0% | 43.3K | |
| CervoMed Inc. Common Stock | $39.9m | $2.52 | -1.9% | 105.0K | |
| Longeveron Inc. Common Stock | $21.6m | $7.21 | -1.0% | 45.1K | |
| OSR Health, Inc. Common Stock | $15.7m | $0.11 | 0.0% | N/A | |
| Greenland Mines Ltd. Common Stock | $15.5m | $3.30 | +4.3% | 522.9K | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $15.2m | $6.27 | 0.0% | 19.8K | |
| FibroBiologics, Inc. Common Stock | $13.0m | $1.59 | -1.2% | 141.5K | |
| Alzamend Neuro, Inc. Common Stock | $8.2m | $1.75 | 0.0% | 23.9K | |
| 20/20 Biolabs, Inc. Common Stock | $8.1m | $0.54 | -5.3% | 41.2K | |
| HCW Biologics Inc. Common Stock | $6.2m | $2.23 | +1.8% | 75.1K |